Zobrazeno 1 - 10 of 244 pro vyhledávání: '"Dong-Hee Na"'
1
Akademický článek
Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia
Autor: Hyelim Kim, Boram Son, Eun U Seo, Miji Kwon, June Hong Ahn, Heungsoo Shin, Gyu Yong Song, Eun Ji Park, Dong Hee Na, Seung‐Woo Cho, Hong Nam Kim, Hee Ho Park, Wonhwa Lee
Publikováno v: Advanced Science, Vol 9, Iss 26, Pp n/a-n/a (2022)
Abstract Severe infectious diseases, such as coronavirus disease 2019 (COVID‐19), can induce hypercytokinemia and multiple organ failure. In spite of the growing demand for peptide therapeutics against infectious diseases, current small molecule‐
Externí odkaz: https://doaj.org/article/1d4087a67cd04417a45b681d99e2ef28
Zobrazit plný text záznamu
2
Akademický článek
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
Autor: Jong-Sung Park, Tae-In Kam, Saebom Lee, Hyejin Park, Yumin Oh, Seung-Hwan Kwon, Jae-Jin Song, Donghoon Kim, Hyunhee Kim, Aanishaa Jhaldiyal, Dong Hee Na, Kang Choon Lee, Eun Ji Park, Martin G. Pomper, Olga Pletnikova, Juan C. Troncoso, Han Seok Ko, Valina L. Dawson, Ted M. Dawson, Seulki Lee
Publikováno v: Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-15 (2021)
Abstract Alzheimer’s disease (AD) is the most common cause of age-related dementia. Increasing evidence suggests that neuroinflammation mediated by microglia and astrocytes contributes to disease progression and severity in AD and other neurodegene
Externí odkaz: https://doaj.org/article/8c12a20bbf914cb084511984a12e33ad
Zobrazit plný text záznamu
4
Akademický článek
Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals
Autor: Jae Cheon Kim, Eun Ji Park, Dong Hee Na
Publikováno v: Pharmaceuticals, Vol 15, Iss 12, p 1585 (2022)
Recently, two oral-administered peptide pharmaceuticals, semaglutide and octreotide, have been developed and are considered as a breakthrough in peptide and protein drug delivery system development. In 2019, the Food and Drug Administration (FDA) app
Externí odkaz: https://doaj.org/article/108ff98093dd48429f36f9d14e0cd0de
Zobrazit plný text záznamu
5
Akademický článek
Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
Autor: Jong-Sung Park, Yumin Oh, Yong Joo Park, Ogyi Park, Hoseong Yang, Stephanie Slania, Laura K. Hummers, Ami A. Shah, Hyoung-Tae An, Jiyeon Jang, Maureen R. Horton, Joseph Shin, Harry C. Dietz, Eric Song, Dong Hee Na, Eun Ji Park, Kwangmeyung Kim, Kang Choon Lee, Viktor V. Roschke, Justin Hanes, Martin G. Pomper, Seulki Lee
Publikováno v: Nature Communications, Vol 10, Iss 1, Pp 1-11 (2019)
Dermal myofibroblasts are responsible for fibrosis development in scleroderma. Here the authors show that a bioengineered recombinant human TRAIL ligand reverses established fibrosis in mouse models of scleroderma by targeting the death receptor 5 an
Externí odkaz: https://doaj.org/article/aeaf85cf976741ac932eb66d3a30c13f
Zobrazit plný text záznamu
7
Akademický článek
Treatment Outcomes and Risk Factors for In-Hospital Mortality in Patients with Acute Aortic Occlusion
Autor: Dong-Hee Na, Deokbi Hwang, Sujin Park, Hyung-Kee Kim, Seung Huh
Publikováno v: Vascular Specialist International, Vol 34, Iss 2, Pp 19-25 (2018)
Purpose: The aims of the present study are to determine the outcomes after acute aortic occlusion (AAO) and analyze the risk factors for in-hospital mortality. Materials and Methods: We retrospectively analyzed 24 patients who were diagnosed wit
Externí odkaz: https://doaj.org/article/d061e7384e1f442095d0b1d221ae04ae
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje